Sanofi to launch 20 new drugs in Japan by 2020

Category: 

29 November 2016
By BioSpectrum Bureau

In Japan, Sanofi is eager to introduce new drugs as generics continue to eat its profits.

Singapore: If reports are to be believed French drug giant Sanofi is all set to launch 20 new drugs in Japan by 2020. In a recently held press meet the company's CEO Mr Jacques Nathan said that among these new drugs, which include existing drugs for new indications, "a significant amount will be biologics.

With drop in sales last year, Sanofi is looking for newer measures to beef up its business in Japan. Sanofi’s sales dropped by 11 percent year-on-year to 261.1 billion yen ($2.3 billion) in 2015. In Japan, Sanofi is eager to introduce new drugs as generics continue to eat its profits. Sanofi’s widely prescribed antiplatelet drug Plavix (clopidogrel), for example, is challenged by the generic version from Tanabe and Sawai.

Read more at: http://www.biospectrumasia.com/biospectrum/news/224559/sanofi-launch-drugs-japan-2020